Altos Labs is a new biotechnology company focused on cellular rejuvenation programming to restore cell health and resilience.
Altos' mission is to restore cell health and resilience to reverse disease, injury, and the disabilities that can occur throughout life.
Altos Labs was founded in 2021 by Rick Klausner and Hans Bishop. The company is headquartered in San Francisco, California, with operations in San Diego, and in Cambridge, UK.
Altos is designed to integrate the best features of academia and industry -- from academia, the freedom to pursue the most challenging problems in biology, and from industry, the focus on a shared mission, ability to foster deep collaborations, and the passion and commitment to transform science into medicines.
The Altos Institutes of Science will pursue deep scientific questions and integrate their findings into one collaborative research effort. The Altos Institute of Medicine will capture knowledge generated about cell health and programming to develop transformative medicines.
Altos Labs was launched with a stagger $3 billion in funding on Jan 19, 2022. Backers included Jeff Bezos, along with other renowned company builders and investors.